NCT00311428View on ClinicalTrials.gov

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

PHASE4CompletedINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

October 31, 2005

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza

Trial Locations (1)

Unknown

University of Tampere Medical School, Tampere

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY